PTPN6 and breast carcinoma: We subsequently divided all 160 breast cancer cases into 4 groups: a high SHP-1 and high EGFR expression group, a high SHP-1 and low EGFR expression group, a low SHP-1 and high EGFR expression group, and a low SHP-1 and low EGFR expression group.